What is Regemat 3D?
Founded in 2015 and headquartered in Granada, Spain, Regemat 3D specializes in the design and manufacturing of cutting-edge medical devices tailored for clinical applications. Beyond its device portfolio, the company is a key developer of bioprinting systems, positioning itself at the intersection of healthcare innovation and advanced manufacturing. This dual focus allows Regemat 3D to address critical needs in both therapeutic treatments and regenerative medicine research.
How much funding has Regemat 3D raised?
Regemat 3D has raised a total of $553K across 1 funding round:
Other Financing Round
$553K
Other Financing Round (2022): $553K, investors not publicly disclosed
What's next for Regemat 3D?
The recent major strategic investment signals a pivotal moment for Regemat 3D, likely enabling accelerated product development, expanded market penetration, and further research into novel bioprinting technologies. This capital infusion is expected to bolster the company's capacity to scale its operations and solidify its position as a leader in the medical device and regenerative medicine industries. Future growth will likely involve strategic partnerships and the commercialization of its advanced bioprinting solutions.
See full Regemat 3D company page
